Indeed, constitutively active mutant of RAC1 (RAC1P29S) is found in 10% of MAPKi progression melanoma tumors and overexpression of PAK may promote MAPKi resistance in some settings (9, 10, 16–18). The gene discussed is RAC1; the disease is melanoma.